MIA O'MARA: Open Payments
NPI 1538717806 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,328 in 93 payments from 18 companies in 2025. Trend: 2023 $1,755 · 2024 $2,015 · 2025 $2,328
Food & beverage: $2,238Education: $90
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 22 | $493 |
| ABBVIE INC. | 13 | $242 |
| Galderma Laboratories, L.P. | 9 | $211 |
| UCB, Inc. | 3 | $200 |
| Arcutis Biotherapeutics, Inc. | 7 | $198 |
| Novartis Pharmaceuticals Corporation | 6 | $166 |
| Integra LifeSciences Corporation | 1 | $166 |
| MAYNE PHARMA COMMERCIAL LLC | 12 | $153 |
| Botanix SB Inc | 1 | $106 |
| Amgen Inc. | 4 | $99 |
Products named: TREMFYA, Bimzelx, Zoryve, SKYRIZI, NEMLUVIO, Integra, SOFDRA, OTEZLA.
Industry payments across FL — which companies pay providers there.
